Attenuation of Responses to Endotoxin by the Triggering Receptor Expressed on Myeloid Cells-1 Inhibitor LR12 in Nonhuman Primate
Authors:
Open Access
- 1 April 2014
- journal article
- critical care-medicine
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 120 (4) , 935-942
Abstract
Background: The triggering receptor expressed on myeloid cells-1 is an immunoreceptor that amplifies the inflammatory response mediated by toll-like receptors engagement. Triggering receptor expressed on myeloid cells-1 inhibitory peptides such LR12 have been shown to prevent hyperresponsiveness and death in several experimental models of septic shock. Methods: Twelve adult male Cynomolgus (Macaca fascicularis) monkeys exposed to an intravenous bolus of endotoxin (10 μg/kg) were randomized to receive LR12 or placebo (n = 6 per group) as an initial intravenous bolus followed by an 8-h continuous intravenous infusion. An additional group of four only received vehicle infusion. Vital signs were monitored for 8 h. Blood was sampled at H0, 1, 2, 4, and 8 for analysis of clinical chemistries, leukocyte count, coagulation parameters, and cytokine plasma concentration. Results: LR12 showed no effect on heart rate and body temperature. By contrast to the placebo group, which experienced a 25 to 40% blood pressure decrease after endotoxin administration, LR12-treated monkeys remained normotensive. Endotoxin induced leukopenia at 2 h (mean leukocyte count, 7.62 g/l vs. 21.1 at H0), which was attenuated by LR12. LR12 also attenuated cytokine production. Conclusions: The triggering receptor expressed on myeloid cells-1 inhibitor LR12 is able to mitigate endotoxin-associated clinical and biological alterations, with no obvious side effects. This study paves the way for future phases Ia and Ib trials in humans.Keywords
This publication has 29 references indexed in Scilit:
- Chronic hypoxia reprograms human immature dendritic cells by inducing a proinflammatory phenotype and TREM‐1 expressionEuropean Journal of Immunology, 2013
- TREM-1: intracellular signaling pathways and interaction with pattern recognition receptorsJournal of Leukocyte Biology, 2013
- A genomic storm in critically injured humansJournal of Experimental Medicine, 2011
- TREM and TREM-like receptors in inflammation and diseaseCurrent Opinion in Immunology, 2009
- Functional genomics of silencing TREM-1 on TLR4 signaling in macrophagesAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2007
- The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptorsNature Immunology, 2007
- Effects of TREM-1 activation in human neutrophils: activation of signaling pathways, recruitment into lipid rafts and association with TLR4International Immunology, 2006
- Modulation of the Triggering Receptor Expressed on the Myeloid Cell Type 1 Pathway in Murine Septic ShockInfection and Immunity, 2006
- A Soluble Form of the Triggering Receptor Expressed on Myeloid Cells-1 Modulates the Inflammatory Response in Murine SepsisJournal of Experimental Medicine, 2004
- TREM-1 amplifies inflammation and is a crucial mediator of septic shockNature, 2001